Apple v. AliveCor (25-1543): Federal Circuit Appeal Voluntarily Dismissed
Apple filed an appeal at the Federal Circuit against AliveCor targeting US10866619B1, a patent covering an electronic device with a sealed button biometric sensing system. The parties agreed to dismiss the proceeding under Fed. R. App. P. 42(b) just 38 days after filing, with each side bearing its own costs.
A 38-day Federal Circuit exit: Apple and AliveCor walk away
On 14 March 2025, Apple, Inc. filed an appeal in Case No. 25-1543 at the Court of Appeals for the Federal Circuit against AliveCor, Inc. The appeal concerned the patentability of US10866619B1, which covers an electronic device having a sealed button biometric sensing system — technology directly relevant to wearable health-monitoring hardware. Apple was represented by Gibson, Dunn & Crutcher, LLP, while AliveCor retained Alston & Bird, LLP.
The proceeding was closed on 21 April 2025, just 38 days after filing, pursuant to a voluntary dismissal agreed by both parties under Fed. R. App. P. 42(b). The court ordered that each side bear its own costs. Because the dismissal was voluntary and the public record does not specify whether it was with or without prejudice, the precise preclusive effect on future challenges to US10866619B1 remains unclear from available filings.
A resolution this early in a Federal Circuit appeal — before any briefing schedule would typically be completed — strongly suggests the parties reached a private accommodation, though no settlement terms have been disclosed publicly. The underlying invalidity or cancellation dispute over the biometric sensing patent may have been resolved bilaterally, or Apple may have elected to abandon the appellate path for strategic reasons. The public record is silent on conditions attached to the dismissal.
Filing to Voluntary dismissal in 38 days
38 days — well below the Federal Circuit’s typical appeal cycle of 12–24 months
Appeal dismissed by agreement: what the Fed. R. App. P. 42(b) exit means
Fed. R. App. P. 42(b): procedural exit with no merits ruling
Rule 42(b) allows parties to a Federal Circuit appeal to jointly stipulate to dismissal before the court reaches the merits. The order here confirms both Apple and AliveCor agreed to the dismissal. Critically, no appellate panel reviewed the patentability questions, meaning no precedential or even persuasive ruling on US10866619B1’s validity was issued. The patent’s legal status is unchanged by this order.
No merits adjudicationThe public record is silent on prejudice terms
A voluntary dismissal under Rule 42(b) may be entered with or without prejudice to refiling. The distinction matters significantly: a with-prejudice dismissal bars Apple from re-raising the same invalidity arguments; a without-prejudice dismissal leaves that door open. The court order as publicly available does not specify which applies, so practitioners should not assume either outcome without reviewing any underlying stipulation filed by the parties.
Prejudice terms undisclosedApple exits without a ruling — strategic calculus unclear
Apple, as appellant, chose to withdraw its challenge before any Federal Circuit briefing reached a decision. This terminates the appellate proceeding but does not necessarily foreclose future PTAB or district court invalidity challenges, depending on the prejudice terms. The 38-day timeline suggests the decision to dismiss was made very shortly after filing, consistent with a rapid change in litigation strategy or an early bilateral resolution.
Appellate challenge withdrawnAliveCor’s biometric patent survives this appellate challenge
For AliveCor, the dismissal means US10866619B1 is not invalidated or cancelled through this proceeding. The patent remains in force, and AliveCor retains enforcement rights. However, because no merits ruling was issued affirming the patent’s validity, the patent has not received additional judicial endorsement. Future competitors or challengers are not formally bound by any finding from this case.
Patent remains enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Apple, Inc. | Company | Consumer electronics company — appellant challenging patentability of US10866619B1Search in Eureka ↗ |
| Defendant | AliveCor, Inc. | Company | Medical-grade ECG and biometric sensing company — holder of US10866619B1Search in Eureka ↗ |
| Plaintiff counsel | Brian Rosenthal | Attorney | Counsel for Apple, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jaysen Chung | Attorney | Counsel for Apple, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Gibson, Dunn & Crutcher, LLP | Law Firm | Representing Apple, Inc.Search in Eureka ↗ |
| Defendant counsel | Christopher Timothy Lawn Douglas | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Erin Beaton | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | J. Ravindra Fernando | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Katherine Rubschlager | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Kirk T. Bradley | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Matthew S. Stevens | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Philip C. Ducker | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant law firm | Alston & Bird, LLP | Law Firm | Representing AliveCor, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The order confirms a consensual dismissal under Fed. R. App. P. 42(b), with no substantive findings on patentability. Because both parties agreed, the Federal Circuit was not required to apply any standard of review to the underlying invalidity or cancellation determinations. The cost-bearing provision — each side pays its own — is consistent with a negotiated exit rather than a concession. The order’s silence on prejudice is the key unresolved question for third-party practitioners assessing whether Apple retains the right to re-challenge US10866619B1.
US10866619B1 — Sealed Button Biometric Sensing System
US10866619B1 (application no. US15/627336) claims an electronic device incorporating a sealed button biometric sensing system — technology directly relevant to wearable devices where hardware buttons double as biometric input surfaces, such as ECG or heart-rate sensors embedded in physical controls. The patent sits at the intersection of industrial design, sealing engineering, and biometric data acquisition, making it broadly applicable to smartwatch and fitness tracker OEMs.
AliveCor’s positioning in medical-grade ECG wearables makes this patent strategically significant beyond consumer electronics. The sealed-button form factor addresses a core design challenge in wearable biometrics: maintaining sensor accuracy while meeting ingress-protection standards. For any hardware team developing wrist-worn or button-integrated health sensors, this patent represents a meaningful freedom-to-operate obstacle. Apple’s decision to challenge — and then withdraw — suggests the patent’s claim scope was taken seriously at the highest levels of IP strategy.
Should you run an FTO analysis against US10866619B1?
Any R&D team developing electronic devices with integrated biometric sensing — particularly where a physical button or control surface doubles as a sensor interface — should treat US10866619B1 as a live clearance risk. This includes smartwatch manufacturers, fitness tracker OEMs, medical wearable developers, and consumer electronics companies incorporating sealed biometric buttons. The patent survived this Federal Circuit appeal without any adverse merits ruling, reinforcing AliveCor’s enforcement position.
PatSnap Eureka’s FTO Search Agent can map the full claim landscape of US10866619B1 against your product architecture, flag potentially blocking claims, identify prior art that was not raised in prior proceedings, and surface related continuation or divisional applications in AliveCor’s portfolio. Given the unresolved prejudice question from this dismissal, proactive clearance is strongly advisable before product launch in this technology space.
Run a freedom-to-operate analysis on US10866619B1 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit biometric patent invalidity appeals
Browse related Federal Circuit appeals involving biometric sensing, wearable health technology patents, and invalidity or cancellation actions in the consumer electronics sector.
What this case signals for the biometric sensing IP landscape
A 38-day Federal Circuit exit between two heavyweight adversaries rarely happens without a story behind it.
Swift voluntary dismissals often signal confidential bilateral terms
When a Federal Circuit appeal closes in under 40 days with each side bearing its own costs, the most common explanation is a private settlement or cross-licensing arrangement. Companies monitoring Apple-AliveCor freedom-to-operate should treat the underlying commercial relationship as potentially restructured, even without public confirmation.
US10866619B1 remains live — FTO clearance is still required
No invalidity ruling issued in this case. Any product team building sealed biometric input systems for wearables must treat US10866619B1 as a live enforcement risk. The absence of a merits ruling means AliveCor can still assert this patent against third parties without the burden of defending a prior adverse finding.
Apple v AliveCor — key questions answered
Apple filed an appeal at the Court of Appeals for the Federal Circuit on 14 March 2025 challenging the patentability of AliveCor’s US10866619B1. The appeal was voluntarily dismissed by agreement of both parties under Fed. R. App. P. 42(b) on 21 April 2025, just 38 days after filing. Each side was ordered to bear its own costs. No merits ruling on the patent’s validity was issued.
Yes. The voluntary dismissal issued no ruling on patentability. US10866619B1 remains in force and AliveCor retains full enforcement rights. The dismissal does not constitute a judicial finding of validity, but equally there is no adverse invalidity determination. Third parties cannot rely on this proceeding for any invalidity argument.
Rule 42(b) of the Federal Rules of Appellate Procedure permits parties to an appeal to agree to dismiss the case before the court issues a ruling. In Case 25-1543, Apple and AliveCor jointly stipulated to dismissal, and the Federal Circuit entered the order accordingly. The rule does not automatically specify whether the dismissal is with or without prejudice — that determination depends on the parties’ agreement, which is not fully disclosed in the public record.
US10866619B1 is a US patent held by AliveCor, Inc. covering an electronic device having a sealed button biometric sensing system. The invention relates to wearable or handheld electronic devices where a physical button or control surface integrates biometric sensing capability — such as ECG or heart-rate detection — while maintaining a sealed, ingress-protected form factor. Application number US15/627336.
The public record does not disclose the reasons. However, a voluntary dismissal under Fed. R. App. P. 42(b) filed just 38 days after appeal — before substantive briefing would typically be completed — is consistent with a rapid bilateral resolution, potentially including a licensing arrangement, cross-license, or strategic withdrawal. Neither party has disclosed settlement terms, and the cost-splitting provision suggests a negotiated rather than unilateral exit.
PatSnap Eureka searches patents and litigation data to answer instantly.